Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

26S Proteasome p50 Inhibitors

The 26S proteasome is a multi-subunit, barrel-shaped enzymatic complex found within cells that plays a pivotal role in protein degradation. This intricate machinery ensures the controlled breakdown of ubiquitinated proteins, thus maintaining the delicate balance of protein synthesis and degradation crucial for cellular homeostasis. The 26S proteasome itself is a combination of the 20S core particle and two 19S regulatory particles. Each component of the 26S proteasome is composed of several subunits, with the p50 being one of the prominent ones in the regulatory complex. The p50 subunit is integral for the proper function of the 26S proteasome, specifically in recognizing polyubiquitin chains attached to substrate proteins.

Inhibitors targeting the 26S proteasome's p50 subunit act by disrupting the recognition and binding of ubiquitinated proteins. These inhibitors are typically small molecules that can dock onto specific regions of the p50 subunit, blocking it from engaging with the ubiquitin chains. As a result, the targeted degradation of proteins by the proteasome is impeded, leading to an accumulation of these proteins within the cell. This disruption in protein turnover can have a cascade effect, affecting various cellular pathways and processes. It's worth noting that inhibiting such a vital cellular component is likely to have widespread cellular effects. The specificity, potency, and selectivity of these inhibitors for the p50 subunit over other proteasomal subunits make them valuable tools in biochemical and cell biology research. Through the study of these inhibitors, researchers can gain a deeper understanding of the intricate functions of the 26S proteasome and the myriad cellular processes it influences.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

Carfilzomib is an irreversible inhibitor of the 20S proteasome, specifically targeting the chymotrypsin-like site. The sustained inhibition results in accumulation of proteotoxic stress leading to cell death.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

Ixazomib is a reversible inhibitor of the 20S proteasome, mainly affecting the chymotrypsin-like activity. This causes an accumulation of ubiquitinated proteins, disrupting cellular processes and promoting apoptosis.

Delanzomib, free base

847499-27-8sc-396774
sc-396774A
5 mg
10 mg
$160.00
$300.00
(0)

Delanzomib is a reversible inhibitor of the 20S proteasome with activity against all three proteolytic sites, resulting in the disruption of protein turnover and subsequent cell death.

Oprozomib

935888-69-0sc-477447
2.5 mg
$280.00
(0)

Oprozomib is an oral, irreversible inhibitor of the 20S proteasome, targeting the chymotrypsin-like activity, leading to proteotoxic stress and induction of apoptosis.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Lactacystin is an irreversible proteasome inhibitor. It forms a covalent bond with the N-terminal threonine of the proteasomal β subunits, inhibiting proteolytic activity and leading to the accumulation of ubiquitinated proteins.

ONX 0914

960374-59-8sc-477437
5 mg
$245.00
(0)

ONX-0914 is a selective inhibitor of the immunoproteasome subunit LMP7. It interferes with antigen presentation and disrupts various immune functions, being researched for its potential in autoimmune disorders.

DBeQ

177355-84-9sc-499943
10 mg
$330.00
1
(0)

DBeQ is a selective, reversible ATP-competitive inhibitor of the p97 ATPase. While not a direct proteasome inhibitor, p97 is involved in the proteostasis network, and its inhibition can lead to accumulation of ubiquitinated proteins.